The latest price target for Omega Therapeutics (NASDAQ: OMGA) was reported by Chardan Capital on September 23, 2022. The analyst firm set a price target for $12.00 expecting OMGA to rise to within 12 months (a possible 99.00% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Omega Therapeutics (NASDAQ: OMGA) was provided by Chardan Capital, and Omega Therapeutics initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Therapeutics was filed on September 23, 2022 so you should expect the next rating to be made available sometime around September 23, 2023.

While ratings are subjective and will change, the latest Omega Therapeutics (OMGA) rating was a initiated with a price target of $0.00 to $12.00. The current price Omega Therapeutics (OMGA) is trading at is $6.03, which is within the analyst's predicted range.